Donghwa Elten Tablets (Erdosteine)

Adult dose

Adults: Administer (take) 300 mg of erdosteine orally 2~3 times daily. When administered for acute respiratory conditions, do not administer continuously for more than 10 days.

This medication should not be used in patients who are allergic to this medication or its components. Patients with liver cirrhosis or cystathionine synthase deficiency should not take this medication as its metabolites may affect methionine metabolism. Patients with peptic ulcers should also refrain from taking this medication. Patients with severe renal impairment and severely impaired liver function should not use this medication as well. This medication contains lactose, therefore patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not use this medication. Patients with mild to moderate liver impairment should use this medication with caution and should not exceed 300mg per day. Diabetic patients or those on a low-calorie diet should also be careful when using this medication syrup. In case of an overdose, symptoms such as excessive sweating, dizziness, and facial flushing may occur. Neurological and respiratory adverse reactions such as headaches, cold symptoms, and breathing difficulties may also arise. Gastrointestinal symptoms like altered taste, nausea, vomiting, diarrhea, abdominal pain, or heartburn may manifest. Skin reactions such as hives, redness, and eczema have been reported as well. Additionally, symptoms such as fatigue, dyspepsia, palpitations, facial or generalized edema, itching, weakness, confusion, and rashes have been observed. This medication should be taken with caution when used in conjunction with expectorants and cough medications, as it may increase the risk of bronchial infection due to difficulty in expelling phlegm and cause issues with bronchial contraction and relaxation. Women who are pregnant or may become pregnant, and those who are breastfeeding should avoid this medication, as its safety has not been sufficiently confirmed. This medication should be kept out of reach of children, and care should be taken not to transfer it to another container, as this poses a risk of accidents and adversely affects quality.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• taste disturbance
• nausea
• vomiting
• diarrhea

Drug interactions

This medication should be discussed with a doctor or pharmacist if taken together with cough medications.

This medication should be kept in a tightly sealed container to prevent exposure to air or moisture. It should be stored at room temperature between 1 to 30 degrees Celsius, away from extreme heat or cold.

Appearance

White rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle